FDA 表示,Abeona 必须满足额外的CMC 要求才...查看全文
产业链观察2023-11-27 22:14
#药闻简讯# $Abeona Therapeutics(ABEO)$ FDA接受并授予Pz-cel BLA的优先审评。
PDUFA 05/25/24.
FDA目前不打算举办AdComm查看全文
SeekingBiotech2023-07-29 20:29
ABEO announced that it has completed the submission of the briefing package to the FDA for its pre-Biologics License Application (BLA) meeting in August 2023$Abeona Therapeutics(ABEO)$查看全文
牛唐2023-07-10 20:22
医药板块速评(2022.07.07)
1、多个7月有数据发布的BIotech股价启动,哪些有配置机会?
2、$Abeona Therapeutics(ABEO)、$居里(CRIS)纷纷增发,是否有上车机会?
3、$Wolfspeed(WOLF)$ 、$ETFMG Alternative Harvest ETF(MJ)$ 、$油气服务ETF-Market Vectors(OIH)$ 等异动,后续走势...查看全文
SeekingBiotech2023-06-09 22:39
$Abeona Therapeutics(ABEO)$
基因治疗候选新药。需要补充材料。
营养不良性大疱性表皮松解症(DEB)(包括隐性营养不良性大疱性表皮松解症-RDEB)
Abeona Therapeutics Announces Regulatory Update on Biologics License Application (BLA) for EB-101查看全文
chuminhua2022-05-18 14:58
5月17日, Ultragenyx Pharmaceutical 已就 Abeona Therapeutics 治疗 A 型Sanfilippo 综合征 ( 黏多糖贮积症 III型,MPS IIIA )在研基因疗法 ABO-102的全球权利达成独家许可协议。 Ultragenyx 将承担 ABO-102(现称为 UX111)的开发责任,Abeona 有资格获得高达净销售额 10% 的分层特许权使用费...查看全文
智通财经APP获悉,11月27日,Abeona Therapeutics(ABEO.US)宣布,美国FDA已接受其在研疗法pz-cel(prademagene zamikeracel,EB-101)的生物制品许可申请(BLA),并授予优先审评资格,该疗法是一款自体、COL7A1基因校正表皮片,用于隐性... 网页链接
$Abeona Therapeutics(ABEO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-026645 Size: 4 KB 网页链接
$Abeona Therapeutics(ABEO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-026641 Size: 4 KB 网页链接
$Abeona Therapeutics(ABEO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-026644 Size: 4 KB 网页链接
$Abeona Therapeutics(ABEO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-026642 Size: 5 KB 网页链接
$Abeona Therapeutics(ABEO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-026643 Size: 4 KB 网页链接
$Abeona Therapeutics(ABEO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-026646 Size: 5 KB 网页链接
$Abeona Therapeutics(ABEO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-026647 Size: 5 KB 网页链接
$Abeona Therapeutics(ABEO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-026649 Size: 5 KB 网页链接
$Abeona Therapeutics(ABEO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-026648 Size: 5 KB 网页链接
$Abeona Therapeutics(ABEO)$ 8-K Current report, items 5.03 and 9.01 Accession Number: 0001493152-24-026640 Act: 34 Size: 362 KB 网页链接